Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazo...

    2025-12-25

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Gold-Standard Tetrazolium Salt for In Vitro Cell Viability Assays

    Executive Summary: MTT is a water-soluble tetrazolium salt used to assess cell viability and metabolic activity through NADH-dependent reduction to formazan—a reaction catalyzed by mitochondrial and extra-mitochondrial enzymes in living cells [DOI]. The assay provides direct, quantitative colorimetric readouts proportional to cell number and metabolic state [internal]. APExBIO's MTT (SKU B7777) is supplied at ≥98% purity, ensuring robust sensitivity and reproducibility for in vitro workflows [product]. MTT is membrane-permeable and cationic, facilitating rapid cellular uptake without intermediates. Solutions are stable for short-term use and require -20°C storage for optimal performance.

    Biological Rationale

    Cell viability and metabolic activity are central readouts in biomedical research, especially in cancer, apoptosis, and drug discovery studies [internal]. The MTT assay leverages cellular reductase activity as a proxy for viability, exploiting mitochondrial and cytosolic enzymes that are abundant in metabolically active, living cells. The yellow MTT salt permeates the cell membrane and is reduced by NADH-dependent oxidoreductases to purple formazan crystals. This correlation enables high-throughput, quantitative screens for cytotoxicity, proliferation, or apoptosis in various in vitro models [internal].

    Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

    MTT is chemically designated as 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (CAS 298-93-1). It is a cationic, membrane-permeable tetrazolium salt. Upon entering viable cells, MTT is reduced by NADH-dependent mitochondrial dehydrogenases and certain cytosolic enzymes to form insoluble formazan crystals [DOI]. The formazan product accumulates intracellularly, and its quantity is directly proportional to the number of metabolically active cells. After incubation (typically 1–4 hours at 37°C), the formazan is solubilized (commonly in DMSO or ethanol) and quantified by measuring absorbance at 540–570 nm. Key mechanistic facts:

    • Reduction is primarily NADH-dependent but can involve other cellular reductases.
    • MTT’s cationic charge enables efficient membrane passage compared to negatively charged alternatives.
    • The reaction does not require exogenous electron carriers or mediators.
    • Formazan crystals are insoluble in aqueous buffers and require organic solvents for extraction.
    For further mechanistic nuance, see this article, which expands on mitochondrial specificity and alternative reduction pathways beyond what is covered here.


    Evidence & Benchmarks

    Applications, Limits & Misconceptions

    MTT is the benchmark for colorimetric cell viability and metabolic activity measurement in vitro. It is routinely used in cancer research, drug toxicity screening, apoptosis assays, and metabolic modulation studies. Its direct NADH-dependent reduction distinguishes it from other tetrazolium salts that may require intermediate electron carriers.

    For a focused discussion on how MTT enables precision cell viability analysis in translational contexts—beyond the scope of this article—see this resource. This current article provides expanded protocol details and mechanistic clarity not included in that overview.

    Common Pitfalls or Misconceptions

    • Non-viable cells do not reduce MTT: Dead or severely damaged cells lack sufficient NADH or active reductases, yielding false negatives if viability is too low.
    • Formazan is insoluble in aqueous media: Proper solubilization requires DMSO or ethanol; incomplete extraction skews absorbance readings.
    • Not suitable for non-adherent cell types without optimization: Suspension cultures may require centrifugation steps to collect formazan.
    • Interfering compounds: Cellular antioxidants or reducing agents in test media can artificially enhance or suppress color development.
    • Limited to endpoint assays: MTT is cytotoxic after reduction and cannot be used for real-time kinetic measurements.

    Workflow Integration & Parameters

    MTT (SKU B7777) from APExBIO is formulated for high-throughput plate-based and manual protocols. Storage at -20°C is recommended for maximal stability. Solutions should be freshly prepared or used within a few hours. Typical working concentrations range from 0.2–0.5 mg/mL in culture medium, with incubation times of 1–4 hours at 37°C. Post-reduction, formazan is solubilized in DMSO, and absorbance is read at 540–570 nm. The product supports integration with automated plate readers and downstream software analysis.

    For a detailed comparison of MTT with other tetrazolium salts and guidance on advanced assay optimization, refer to this article; the present text emphasizes APExBIO's purity specifications and workflow flexibility not addressed in the linked guide.

    Conclusion & Outlook

    MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) remains the gold-standard reagent for colorimetric cell viability and metabolic activity assays in vitro. Its NADH-dependent mechanism, high membrane permeability, and robust reproducibility underpin its widespread adoption in biomedical research. APExBIO’s high-purity MTT (SKU B7777) ensures sensitive, quantitative results across cancer, apoptosis, and drug discovery workflows [APExBIO product page]. Ongoing innovation in assay miniaturization and digital analysis is expected to further expand MTT’s utility in translational research.